Pakeeza Arzoo Shaiq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pakeeza Arzoo Shaiq has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Ghazala Kaukab Raja
University Institute of Biochemistry & Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawal-pindi, 46000, Pakistan, Pakistan
10 shared publications - Muhammad Ilyas
Faculty of Rehabilitation and Allied Health Sciences, Ripah International University, Malakand Campus, KPK, Pakistan, Pakistan
5 shared publications - Asad Mehmood Raja
University Institute of Biochemistry & Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawal-pindi, 46000, Pakistan, Pakistan
4 shared publications - Muhammad Javaid Asad
University Institute of Biochemistry & Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawal-pindi, 46000, Pakistan, Pakistan
4 shared publications - Muhammad Noor Ul Amin
University Institute of Biochemistry & Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawalpindi, 46000, Pakistan, Pakistan
4 shared publications - Rafaqat Ishaq
University Institute of Biochemistry & Biotechnology, Pir Mehr Ali Shah Arid Agriculture University, Rawal-pindi, 46000, Pakistan, Pakistan
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by King Edward Medical University in Annals of King Edward Medical University
- Vol. 32 (3) , 326-333
Risk Factors Associated with Sputum Smear-Positive Tuberculosis in Urban Pakistan: A Study from Rawalpindi and Islamabad
Background: Sputum smear-positive tuberculosis (TB) is a highly infectious form of active TB with a high mycobacterial load and greater transmission potential than sputum smear-negative TB. Objective: The study aimed to identify key socio-demographic and clinical predictors of sputum smear-positive tuberculosis in Rawalpindi and Islamabad, Pakistan. Methods: A cross-sectional study was conducted among 1,000 TB patients. Data on clinical symptoms, demographics, and medical history were collected via a structured questionnaire. Chi- square (χ2) test and multivariate logistic regression model were used to analyse associations and predictors of sputum smear-positive TB. Results: Of the 1000 TB patients, 86.1% had pulmonary TB, of whom 55.2% were sputum smear-positive. Significant factors associated with sputum smear-positivity included socio-demographic factors (age, gender, educational level, income) and clinical factors (BCG vaccination status, family history, TB stage and smoking status) (p<0.05). Independent predictors for sputum smear-positive TB were BCG vaccination (OR=2.95, 95% CI: 2.04-4.2, p<0.005), TB recurrence (OR=5.37, 95% CI: 2.40-13.36, p<0.005), and smoking (OR=1.92, 95% CI: 1.22-3.05, p=0.005). Low educational status was also associated, though with an odds ratio below 1. Conclusion: This study identifies key socio-demographic and clinical factors associated with sputum smear-positive tuberculosis in Rawalpindi and Islamabad with BCG vaccination status, TB recurrence, and smoking emerging as significant strong predictors. These findings highlight the need of targeted, policy-focused particularly smoking cessation, improved follow-up of TB patients and optimized TB vaccines to reduce transmission and strengthen urban TB control.
- 30 September 2026
- Published by King Edward Medical University in Annals of King Edward Medical University
- Vol. 32 (3) , 326-333
Open AccessRisk Factors Associated with Sputum Smear-Positive Tuberculosis in Urban Pakistan: A Study from Rawalpindi and Islamabad
Background: Sputum smear-positive tuberculosis (TB) is a highly infectious form of active TB with a high mycobacterial load and greater transmission potential than sputum smear-negative TB. Objective: The study aimed to identify key socio-demographic and clinical predictors of sputum smear-positive tuberculosis in Rawalpindi and Islamabad, Pakistan. Methods: A cross-sectional study was conducted among 1,000 TB patients. Data on clinical symptoms, demographics, and medical history were collected via a structured questionnaire. Chi- square (χ2) test and multivariate logistic regression model were used to analyse associations and predictors of sputum smear-positive TB. Results: Of the 1000 TB patients, 86.1% had pulmonary TB, of whom 55.2% were sputum smear-positive. Significant factors associated with sputum smear-positivity included socio-demographic factors (age, gender, educational level, income) and clinical factors (BCG vaccination status, family history, TB stage and smoking status) (p<0.05). Independent predictors for sputum smear-positive TB were BCG vaccination (OR=2.95, 95% CI: 2.04-4.2, p<0.005), TB recurrence (OR=5.37, 95% CI: 2.40-13.36, p<0.005), and smoking (OR=1.92, 95% CI: 1.22-3.05, p=0.005). Low educational status was also associated, though with an odds ratio below 1. Conclusion: This study identifies key socio-demographic and clinical factors associated with sputum smear-positive tuberculosis in Rawalpindi and Islamabad with BCG vaccination status, TB recurrence, and smoking emerging as significant strong predictors. These findings highlight the need of targeted, policy-focused particularly smoking cessation, improved follow-up of TB patients and optimized TB vaccines to reduce transmission and strengthen urban TB control.
- Open Access
Complexity of Inheritance of Pathogenic Mutations Associated with Epilepsy in Consanguine Families from Pakistan
Background/Objectives: Consanguine families are helpful to identify recessive candidate genes for inherited diseases, but can also show an unusual inheritance pattern of pathogenic mutations. In this case series, we demonstrate this in five consanguine families with epilepsy from Pakistan. Methods: We performed whole exome sequencing of respective index patients, analyzed the data using two different models for inheritance of mutations and determined the segregation pattern of relevant mutations in the families by bi-directional Sanger sequencing. Results: Apart from mutations in classical dominant epilepsy genes (TSC2, DEPDC5, and CACNA1I), pathogenic mutations in rare recessive epilepsy-related genes (PGAP2, NOVA2, and CCDC88C) were also identified. Interestingly, we were able to provide evidence that GALR2 is potentially an additional gene associated with a recessive form of epilepsy. In one family, a homozygous ‘pathogenic’ TRAF3IP1 p. Gly387* nonsense mutation was identified, which, most probably due to stop-codon read-through, did not contribute to the phenotype. Conclusions: Our case series of consanguine families with epilepsy exemplifies the inheritance pattern of mutations in rare recessive epilepsy genes, and shows that mutations in classical epilepsy genes showing dominant or sporadic inheritance can also be relevant. That requires the analysis of whole exome data on the basis of different inheritance models.
Open AccessComplexity of Inheritance of Pathogenic Mutations Associated with Epilepsy in Consanguine Families from Pakistan
Background/Objectives: Consanguine families are helpful to identify recessive candidate genes for inherited diseases, but can also show an unusual inheritance pattern of pathogenic mutations. In this case series, we demonstrate this in five consanguine families with epilepsy from Pakistan. Methods: We performed whole exome sequencing of respective index patients, analyzed the data using two different models for inheritance of mutations and determined the segregation pattern of relevant mutations in the families by bi-directional Sanger sequencing. Results: Apart from mutations in classical dominant epilepsy genes (TSC2, DEPDC5, and CACNA1I), pathogenic mutations in rare recessive epilepsy-related genes (PGAP2, NOVA2, and CCDC88C) were also identified. Interestingly, we were able to provide evidence that GALR2 is potentially an additional gene associated with a recessive form of epilepsy. In one family, a homozygous ‘pathogenic’ TRAF3IP1 p. Gly387* nonsense mutation was identified, which, most probably due to stop-codon read-through, did not contribute to the phenotype. Conclusions: Our case series of consanguine families with epilepsy exemplifies the inheritance pattern of mutations in rare recessive epilepsy genes, and shows that mutations in classical epilepsy genes showing dominant or sporadic inheritance can also be relevant. That requires the analysis of whole exome data on the basis of different inheritance models.
- Open Access
- 30 June 2025
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (2) , 197-206
Validation of CDKN2A Variant rs10757278 in Pakistani Cardiomyopathy Patients
Objectives: This study aimed to evaluate the association of the rs10757278 single nucleotide polymorphism (SNP) with cardiomyopathy, particularly its role in genetic susceptibility to ischemic dilated cardiomyopathy (IDCM). Methodology: A case-control study was conducted including 200 participants—100 cardiomyopathy patients and 100 healthy controls. Clinical and echocardiographic parameters were systematically recorded. Genotyping for rs10757278 was performed using tetra-primer ARMS-PCR. Allele and genotype frequencies were analyzed with odds ratios, and Hardy-Weinberg equilibrium was assessed to determine genetic association. Results: Logistic regression analysis revealed a significant association of rs10757278 with cardiomyopathy (Chi-square = 11.679, p = 0.00291) in both allelic and genotypic distributions. The GG genotype (p = 0.00958) conferred an increased risk, with the G allele identified as the risk allele. Among cardiomyopathy subtypes, IDCM showed a significant association with rs10757278, particularly with the GG and AG genotypes (p = 0.02613 and p = 0.00104, respectively). Logistic regression indicated that the G allele substantially increased IDCM risk (p = 0.0031, OR = 3.19, 95% CI = 1.51–7.17), while the A allele appeared protective (p = 0.00961, OR = 0.35, 95% CI = 0.15–0.77). This SNP, a known genome-wide association study (GWAS) hit, is strongly linked to coronary artery disease (CAD) and ischemic dilated cardiomyopathy, highlighting its potential as a biomarker for cardiomyopathy risk stratification. Conclusion: The rs10757278 variant is significantly associated with cardiomyopathies, particularly ischemic dilated cardiomyopathy, in the Pakistani population. The G allele serves as a genetic predictor of disease susceptibility. Larger, multi-center studies are warranted to validate these findings and facilitate early diagnosis and genetic risk profiling for cardiomyopathies.
- 30 June 2025
- Published by Pakistan Cardiac Society in Pakistan Heart Journal
- Vol. 58 (2) , 197-206
Open AccessValidation of CDKN2A Variant rs10757278 in Pakistani Cardiomyopathy Patients
Objectives: This study aimed to evaluate the association of the rs10757278 single nucleotide polymorphism (SNP) with cardiomyopathy, particularly its role in genetic susceptibility to ischemic dilated cardiomyopathy (IDCM). Methodology: A case-control study was conducted including 200 participants—100 cardiomyopathy patients and 100 healthy controls. Clinical and echocardiographic parameters were systematically recorded. Genotyping for rs10757278 was performed using tetra-primer ARMS-PCR. Allele and genotype frequencies were analyzed with odds ratios, and Hardy-Weinberg equilibrium was assessed to determine genetic association. Results: Logistic regression analysis revealed a significant association of rs10757278 with cardiomyopathy (Chi-square = 11.679, p = 0.00291) in both allelic and genotypic distributions. The GG genotype (p = 0.00958) conferred an increased risk, with the G allele identified as the risk allele. Among cardiomyopathy subtypes, IDCM showed a significant association with rs10757278, particularly with the GG and AG genotypes (p = 0.02613 and p = 0.00104, respectively). Logistic regression indicated that the G allele substantially increased IDCM risk (p = 0.0031, OR = 3.19, 95% CI = 1.51–7.17), while the A allele appeared protective (p = 0.00961, OR = 0.35, 95% CI = 0.15–0.77). This SNP, a known genome-wide association study (GWAS) hit, is strongly linked to coronary artery disease (CAD) and ischemic dilated cardiomyopathy, highlighting its potential as a biomarker for cardiomyopathy risk stratification. Conclusion: The rs10757278 variant is significantly associated with cardiomyopathies, particularly ischemic dilated cardiomyopathy, in the Pakistani population. The G allele serves as a genetic predictor of disease susceptibility. Larger, multi-center studies are warranted to validate these findings and facilitate early diagnosis and genetic risk profiling for cardiomyopathies.
- Open Access
- 30 January 2025
- Published by MDPI AG in Preprints.org
Apolipoproteins and the ApoB/ApoA-1 Ratio as Superior Diagnostic and Prognostic Markers for CAD in a Pakistani Population
Background & Objectives: Apolipoproteins, specifically ApoA-I (a cardioprotective HDL component) and ApoB (associated with cardiovascular risk), are increasingly recognized for their value in diagnosing and predicting heart disease. This study focused on comparing these markers and the ApoB/ApoA-I ratio with traditional lipid profiles to assess their diagnostic and prognostic capabilities. Methods: In this cross-sectional study, 1,200 participants were categorized into three groups: control (n=250), training (n=450), and validation (n=500). Blood samples were analyzed for ApoB, ApoA-I, and conventional lipid profile. Advanced statistical methods, including logistic regression, ROC curve analyses, and propensity score matching, were applied to control for confounding factors and validate findings. Results: The training cohort showed significantly higher ApoB levels (1.20 ± 0.52 g/L) compared to controls (1.0 ± 0.40 g/L, p < 0.001), while ApoA-I levels were significantly lower (1.03 ± 0.34 g/L vs. 1.12 ± 0.34 g/L, p = 0.045). The ApoB/ApoA-I ratio was markedly elevated in the training group (1.46 ± 0.18) versus controls (1.06 ± 0.95, p < 0.001). ApoB proved to be the most reliable predictor of coronary artery disease with an AUC of 0.82, surpassing the ApoB/ApoA-I ratio (AUC 0.70) and ApoA-I (AUC 0.65). Cholesterol and triglycerides demonstrated weaker associations with CAD. Conclusion: ApoB and the ApoB/ ApoA-I ratio are superior markers for assessing CAD risk compared to traditional lipid profile. This investigation lends further support for incorporating apolipoprotein testing into clinical practice, enhancing CAD risk stratification, in particular for the high-risk population.
- 30 January 2025
- Published by MDPI AG in Preprints.org
Open AccessApolipoproteins and the ApoB/ApoA-1 Ratio as Superior Diagnostic and Prognostic Markers for CAD in a Pakistani Population
Background & Objectives: Apolipoproteins, specifically ApoA-I (a cardioprotective HDL component) and ApoB (associated with cardiovascular risk), are increasingly recognized for their value in diagnosing and predicting heart disease. This study focused on comparing these markers and the ApoB/ApoA-I ratio with traditional lipid profiles to assess their diagnostic and prognostic capabilities. Methods: In this cross-sectional study, 1,200 participants were categorized into three groups: control (n=250), training (n=450), and validation (n=500). Blood samples were analyzed for ApoB, ApoA-I, and conventional lipid profile. Advanced statistical methods, including logistic regression, ROC curve analyses, and propensity score matching, were applied to control for confounding factors and validate findings. Results: The training cohort showed significantly higher ApoB levels (1.20 ± 0.52 g/L) compared to controls (1.0 ± 0.40 g/L, p < 0.001), while ApoA-I levels were significantly lower (1.03 ± 0.34 g/L vs. 1.12 ± 0.34 g/L, p = 0.045). The ApoB/ApoA-I ratio was markedly elevated in the training group (1.46 ± 0.18) versus controls (1.06 ± 0.95, p < 0.001). ApoB proved to be the most reliable predictor of coronary artery disease with an AUC of 0.82, surpassing the ApoB/ApoA-I ratio (AUC 0.70) and ApoA-I (AUC 0.65). Cholesterol and triglycerides demonstrated weaker associations with CAD. Conclusion: ApoB and the ApoB/ ApoA-I ratio are superior markers for assessing CAD risk compared to traditional lipid profile. This investigation lends further support for incorporating apolipoprotein testing into clinical practice, enhancing CAD risk stratification, in particular for the high-risk population.
- Open Access
- 21 January 2025
- Published by MDPI AG in Preprints.org
Validation of GWAS-Identified CDKN2A Variant rs10757278 in Cardiomyopathy Patients of Pakistani Cohort
Cardiomyopathies, a leading cause of heart failure and mortality worldwide, are a diverse group of heart muscle disorders, with dilated cardiomyopathy being the most prevalent subtype. Numerous genetic variants, identified through GWAS and candidate gene studies, are associated with cardiomyopathies. This study aimed to evaluate the association of the rs10757278 SNP polymorphism on chromosome 9p21.3 near the CDKN2A and CDKN2B genes with cardiomyopathy, focusing on its role in genetic susceptibility to ischemic dilated cardiomyopathy. Methods: A case-control study was conducted with 200 participants (100 cardiomyopathy patients and 100 controls). Clinical and echocardiographic parameters were recorded, and genotyping was performed using tetra-arms PCR. Results: Statistical analysis revealed that rs10757278 was significantly associated with cardiomyopathy (Chi-sq=11.679, p=0.00291) in allelic and genotypic distributions. The GG genotype (p=0.00958) increased risk, identifying the G allele as the risk allele. For IDCM, significant associations were observed for GG and AG genotypes (p=0.02613, p=0.00104), with the G allele increasing risk (p=0.0031, OR=3.19, CI=1.51–7.17) and the A allele offering protection (p=0.00961, OR=0.35, CI=0.15–0.177). Conclusion: These findings highlight rs10757278 as a potential biomarker for cardiomyopathy risk profiling. Further large-scale studies are warranted to confirm these results and improve early diagnosis and genetic risk prediction for cardiomyopathies.
- 21 January 2025
- Published by MDPI AG in Preprints.org
Open AccessValidation of GWAS-Identified CDKN2A Variant rs10757278 in Cardiomyopathy Patients of Pakistani Cohort
Cardiomyopathies, a leading cause of heart failure and mortality worldwide, are a diverse group of heart muscle disorders, with dilated cardiomyopathy being the most prevalent subtype. Numerous genetic variants, identified through GWAS and candidate gene studies, are associated with cardiomyopathies. This study aimed to evaluate the association of the rs10757278 SNP polymorphism on chromosome 9p21.3 near the CDKN2A and CDKN2B genes with cardiomyopathy, focusing on its role in genetic susceptibility to ischemic dilated cardiomyopathy. Methods: A case-control study was conducted with 200 participants (100 cardiomyopathy patients and 100 controls). Clinical and echocardiographic parameters were recorded, and genotyping was performed using tetra-arms PCR. Results: Statistical analysis revealed that rs10757278 was significantly associated with cardiomyopathy (Chi-sq=11.679, p=0.00291) in allelic and genotypic distributions. The GG genotype (p=0.00958) increased risk, identifying the G allele as the risk allele. For IDCM, significant associations were observed for GG and AG genotypes (p=0.02613, p=0.00104), with the G allele increasing risk (p=0.0031, OR=3.19, CI=1.51–7.17) and the A allele offering protection (p=0.00961, OR=0.35, CI=0.15–0.177). Conclusion: These findings highlight rs10757278 as a potential biomarker for cardiomyopathy risk profiling. Further large-scale studies are warranted to confirm these results and improve early diagnosis and genetic risk prediction for cardiomyopathies.
- 16 December 2023
- Published by Elsevier in Epilepsy Research
- Vol. 201, 107283
Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families
- 16 December 2023
- Published by Elsevier in Epilepsy Research
- Vol. 201, 107283
Whole exome sequencing identifies variable expressivity of CLN6 variants in Progressive myoclonic epilepsy affected families
- 27 July 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 116, 74-80
Whole-Exome sequencing identifies GYS2 biallelic variants in individuals with suspected epilepsy
- 27 July 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 116, 74-80
Whole-Exome sequencing identifies GYS2 biallelic variants in individuals with suspected epilepsy
- Open Access
Whole Exome Sequencing Reveals Clustering of Variants of Known Vitiligo Genes in Multiplex Consanguineous Pakistani Families
Vitiligo is an autoimmune complex pigmentation disease characterized by non-pigmented patches on the surface of the skin that affect approximately 0.5–2% population worldwide. The exact etiology is still unknown; however, vitiligo is hypothesized to be a multifactorial and genetically heterogeneous condition. Therefore, the current study is designed to investigate the anthropometric presentation and genetic spectrum of vitiligo in fifteen consanguineous Pakistani families. The clinical evaluation of participating individuals revealed varying degrees of disease severity, with 23 years as the average age of disease onset. The majority of the affected individuals had non-segmental vitiligo (NSV). Whole exome sequencing analysis revealed clustering of rare variants of known vitiligo-associated genes. For instance, in the affected individuals of family VF-12, we identified three novel rare variants of PTPN22 (c.1108C>A), NRROS (c.197C>T) and HERC2 (c.10969G>A) genes. All three variants replaced evolutionarily conserved amino acid residues in encoded proteins, which are predicted to impact the ionic interactions in the secondary structure. Although various in silico algorithms predicted low effect sizes for these variants individually, the clustering of them in affected individuals increases the polygenic burden of risk alleles. To our knowledge, this is the first study that highlights the complex etiology of vitiligo and genetic heterogeneity in multiplex consanguineous Pakistani families.
Open AccessWhole Exome Sequencing Reveals Clustering of Variants of Known Vitiligo Genes in Multiplex Consanguineous Pakistani Families
Vitiligo is an autoimmune complex pigmentation disease characterized by non-pigmented patches on the surface of the skin that affect approximately 0.5–2% population worldwide. The exact etiology is still unknown; however, vitiligo is hypothesized to be a multifactorial and genetically heterogeneous condition. Therefore, the current study is designed to investigate the anthropometric presentation and genetic spectrum of vitiligo in fifteen consanguineous Pakistani families. The clinical evaluation of participating individuals revealed varying degrees of disease severity, with 23 years as the average age of disease onset. The majority of the affected individuals had non-segmental vitiligo (NSV). Whole exome sequencing analysis revealed clustering of rare variants of known vitiligo-associated genes. For instance, in the affected individuals of family VF-12, we identified three novel rare variants of PTPN22 (c.1108C>A), NRROS (c.197C>T) and HERC2 (c.10969G>A) genes. All three variants replaced evolutionarily conserved amino acid residues in encoded proteins, which are predicted to impact the ionic interactions in the secondary structure. Although various in silico algorithms predicted low effect sizes for these variants individually, the clustering of them in affected individuals increases the polygenic burden of risk alleles. To our knowledge, this is the first study that highlights the complex etiology of vitiligo and genetic heterogeneity in multiplex consanguineous Pakistani families.
- Open Access
- 26 February 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 407
Differential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents
Schizophrenia patients demonstrate variations in response to different therapies that are currently being used for the treatment of disorders, such as augmentation therapy (ECT or mood stabilizer) and combination therapy (with antipsychotics). These therapies are also used to treat schizophrenia patients in Pakistan; however, patients show poor overall response. Therefore, this study was conducted to investigate the association between the patients’ response to treatment and the use of antipsychotic agents, with variability in overall response, within different groups of patients. Methods: We conducted a retrospective study that included schizophrenia subjects (N = 200) belonging to different age groups, ethnicities, and regions from different outpatient and inpatient departments in psychiatric institutes located in different cities of Pakistan. These patients were assessed for their response to treatment therapies and categorized into four groups (non-responders (N-R), slow response (S-R), patients with relapse, and completely recovered patients (C-R)) according to their responses. Results: The final analysis included 200 subjects, of which 73.5% were males. Mean age was 34 ± 10 years. Percentage of N-R was 5%, S-R was 42%, patients with relapse were 24%, and C-R was 1.5%. The generalized linear regression model shows a significant association between medication response and age (p = 0.0231), age of onset (p = 0.0086), gender (p = 0.005), and marital status (p = 0.00169). Variability within the medication responses was a result of the treatment regime followed. Antipsychotic agents were significantly associated with the treatment response (p = 0.00258, F = 4.981) of the patients. Significant variation was also observed in the treatment response (p = 0.00128) of the patients that were given augmentation therapy as well as combination therapy. Conclusion: The data suggests proper monitoring of patients’ behavior in response to treatment therapies to implement tailored interventions. Despite several genetic studies supporting the heritability of schizophrenia, an insignificant association between characteristic features and family history might have been due to the limited sample size, suggesting collaborative work with massive sample sizes.
- 26 February 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 407
Open AccessDifferential Treatment Responses in Pakistani Schizophrenia Samples: Correlation with Sociodemographic Parameters, Drug Addiction, Attitude to the Treatment and Antipsychotic Agents
Schizophrenia patients demonstrate variations in response to different therapies that are currently being used for the treatment of disorders, such as augmentation therapy (ECT or mood stabilizer) and combination therapy (with antipsychotics). These therapies are also used to treat schizophrenia patients in Pakistan; however, patients show poor overall response. Therefore, this study was conducted to investigate the association between the patients’ response to treatment and the use of antipsychotic agents, with variability in overall response, within different groups of patients. Methods: We conducted a retrospective study that included schizophrenia subjects (N = 200) belonging to different age groups, ethnicities, and regions from different outpatient and inpatient departments in psychiatric institutes located in different cities of Pakistan. These patients were assessed for their response to treatment therapies and categorized into four groups (non-responders (N-R), slow response (S-R), patients with relapse, and completely recovered patients (C-R)) according to their responses. Results: The final analysis included 200 subjects, of which 73.5% were males. Mean age was 34 ± 10 years. Percentage of N-R was 5%, S-R was 42%, patients with relapse were 24%, and C-R was 1.5%. The generalized linear regression model shows a significant association between medication response and age (p = 0.0231), age of onset (p = 0.0086), gender (p = 0.005), and marital status (p = 0.00169). Variability within the medication responses was a result of the treatment regime followed. Antipsychotic agents were significantly associated with the treatment response (p = 0.00258, F = 4.981) of the patients. Significant variation was also observed in the treatment response (p = 0.00128) of the patients that were given augmentation therapy as well as combination therapy. Conclusion: The data suggests proper monitoring of patients’ behavior in response to treatment therapies to implement tailored interventions. Despite several genetic studies supporting the heritability of schizophrenia, an insignificant association between characteristic features and family history might have been due to the limited sample size, suggesting collaborative work with massive sample sizes.
- Open Access
Whole-Exome Sequencing of Pakistani Consanguineous Families Identified Pathogenic Variants in Genes of Intellectual Disability
Intellectual disability (ID) is a condition of significant limitation of cognitive functioning and adaptive behavior, with 50% of etiology attributed to genetic predisposition. We recruited two consanguineous Pakistani families manifesting severe ID and developmental delay. The probands were subjected to whole exome sequencing (WES) and variants were further prioritized based on population frequency, predicted pathogenicity and functional relevance. The WES data analysis identified homozygous pathogenic variants in genes MBOAT7 and TRAPPC9. The pathogenicity of the variants was supported by co-segregation analysis and in silico tool. The findings of this study expand mutation spectrum and provide additional evidence to the role of MBOAT7 and TRAPPC9 in causation of ID.
Open AccessWhole-Exome Sequencing of Pakistani Consanguineous Families Identified Pathogenic Variants in Genes of Intellectual Disability
Intellectual disability (ID) is a condition of significant limitation of cognitive functioning and adaptive behavior, with 50% of etiology attributed to genetic predisposition. We recruited two consanguineous Pakistani families manifesting severe ID and developmental delay. The probands were subjected to whole exome sequencing (WES) and variants were further prioritized based on population frequency, predicted pathogenicity and functional relevance. The WES data analysis identified homozygous pathogenic variants in genes MBOAT7 and TRAPPC9. The pathogenicity of the variants was supported by co-segregation analysis and in silico tool. The findings of this study expand mutation spectrum and provide additional evidence to the role of MBOAT7 and TRAPPC9 in causation of ID.